Pharma Market Access Insights - from Mtech Access

Questions Time Special - Views from across the NHS; from costings to strategy to clinical care

July 30, 2020 Mtech Access Season 1 Episode 8
Pharma Market Access Insights - from Mtech Access
Questions Time Special - Views from across the NHS; from costings to strategy to clinical care
Show Notes Chapter Markers

In this 'Questions Time' special we welcome a broad panel of practitioners from across the NHS to explore the themes of care delivery, collaboration, innovation and governance. Our panellists are:

  • Cameron Ward (Interim Director of Strategy and Outcomes, Sefton CCG)
  • Hilary Snowdon (Management Lead, West Northumberland PCN)
  • Patrick McGinley (Head of Costing & SLR, Maidstone & Tunbridge Wells NHS Trust)
  • Dr Su McCole (GP & Area Clinical Director)

This episode is part of our COVID-19 series, where Tom Clarke (Director -  NHS Insights & Interaction, Mtech Access) asks experts holding operational, strategic and clinical roles across the NHS to share their experiences and insights into how the NHS has responded to COVID-19 and the wider challenges facing the health service.

In this special 1-hour episode, our panellists explore:

Care delivery:

  • What will happen to elective procedures over the next few months - how will they be prioritised & delivered?
  • How will services begin to mobilise themselves while the threat of a second (and subsequent) wave remains?

                   
Collaboration:

  • What are the highlights you have seen locally in approaches to collaborative working?
  • Do you think trust has been built in partnership working that will continue post COVID, both within the NHS and with external partners?
  • What has been your experience of working with the pharmaceutical industry during this COVID pandemic?


Innovation: 

  • How will innovations that have happened during COVID be evaluated so the best ones are kept? 
  • What elements of the remote care used, evolved or developed during the pandemic will become standard elements of NHS care, and in what time frame?
  • What risks are attached with the innovations we have seen during COVID?

                               
Governance: 

  • What lasting ‘relaxation’ effects on NHS governance (engagement; medicine trials; budgets etc.) do you anticipate as remaining post pandemic?
  • What part do you expect the NHS to play in covering the ‘COVID bill’ that the country has been left with?

This episode was originally broadcast on 5th June 2020 as a webinar. This podcast series has been converted from our webinar series 'How is COVID-19 impacting the NHS?'.

Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/  

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

Care Delivery - How will services begin to mobilise themselves while the threat of a second (and subsequent) wave remains?
Care Delivery - What will happen to elective procedures over the next few months - how will they be prioritised & delivered?
Governance - What lasting ‘relaxation’ effects on NHS governance (engagement; medicine trials; budgets etc.) due you anticipate as remaining post pandemic?
Governance / Collaboration - How has trust been impacted?
Collaboration - Has there been a big step forward in integration and will this be long lasting?
Collaboration - The role of the private sector
Collaboration - Where is there opportunity for the pharma industry to support the NHS?
Innovation - How will innovations that have happened during Covid be evaluated so the best ones are kept?